Decreased endogenous circulating Steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment.

Mitchell S. Cairo(New York Medical College), Y Suen(Children's Hospital of Orange County), Joel Weinthal, Carmella van de Ven(Children's Hospital of Orange County), Jeffrey S. Buzby(Children's Hospital of Orange County), Eileen Gillan, W. G. Ho, Violet Shen(Ruhr University Bochum), S. Yancik

PubMed

February 1, 1993

Cited by 17

Related Papers

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

|Journal of Clinical Oncology|2008|794

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

|Journal of Clinical Oncology|2006|309

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead

|Journal of Clinical Oncology|2015|288